Simple blood test may spot diabetes early in obese kids
NCT ID NCT06682481
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a substance in the blood called 1,5-anhydroglucitol can serve as a marker for how well the pancreas is working in obese children, with or without type 2 diabetes. Researchers will measure levels of this marker in 50 children aged 12 to 16 and compare them to healthy volunteers. The goal is to find a simple way to detect early problems with insulin-producing beta cells, which could lead to better monitoring and prevention of diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
1,5-anhydroglucitol (a blood sugar marker)
What this could lead to
If successful, this could provide a simple blood test to detect early beta-cell problems in obese children, helping to prevent or manage type 2 diabetes.
What could go wrong
This is a small, early observational study (50 children) that only measures a biomarker, not a treatment. The marker may not prove reliable enough for clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
University Hospital of Geneva
RECRUITINGGeneva, Canton of Geneva, 1211, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact